Sequoia Financial Advisors LLC Has $1.24 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sequoia Financial Advisors LLC boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 42.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,217 shares of the company’s stock after buying an additional 3,941 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,240,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Plimoth Trust Co. LLC boosted its holdings in GE HealthCare Technologies by 73.6% in the third quarter. Plimoth Trust Co. LLC now owns 7,601 shares of the company’s stock valued at $713,000 after acquiring an additional 3,222 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of GE HealthCare Technologies by 2.6% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 74,115 shares of the company’s stock valued at $6,956,000 after purchasing an additional 1,879 shares during the last quarter. Whittier Trust Co. grew its position in shares of GE HealthCare Technologies by 4.7% during the 3rd quarter. Whittier Trust Co. now owns 121,569 shares of the company’s stock worth $11,409,000 after buying an additional 5,441 shares during the period. Koss Olinger Consulting LLC bought a new stake in shares of GE HealthCare Technologies during the third quarter worth approximately $241,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in GE HealthCare Technologies by 2.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock valued at $2,317,000 after buying an additional 562 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.27% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have commented on GEHC. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research report on Wednesday, September 18th. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their target price for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. Stifel Nicolaus increased their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. Finally, Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $94.23.

GE HealthCare Technologies Trading Down 0.5 %

GEHC opened at $88.42 on Friday. The stock has a market capitalization of $40.36 billion, a P/E ratio of 25.85, a P/E/G ratio of 3.39 and a beta of 1.18. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.55. The firm’s fifty day simple moving average is $88.42 and its 200 day simple moving average is $83.45.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. During the same period in the prior year, the firm earned $0.92 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up .5% compared to the same quarter last year. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.